GAITHERSBURG, Md. — Emergent BioSolutions Inc. applauded Congress and President George W. Bush on Dec. 20, 2006, as he signed into law the Pandemic and All-Hazards Preparedness Act.
It authorizes appropriations through 2011 to improve bioterrorism and other public health emergency planning and preparedness activities and creates the Biomedical Advanced Research and Development Authority, under the direction of the Department of Health and Human Services, which will be focused on directing advanced research and development of vaccines and therapeutics for use against biological attacks.
“I congratulate Congress on passing this comprehensive legislation and the president for signing it into law. It is an important signal to the biopharmaceutical industry regarding the government’s commitment to access effective bioterror countermeasures,” said Fuad El-Hibri, chairman and CEO of Emergent BioSolutions. “This legislation should enable the U.S. government to better develop, procure and make available countermeasures that can help protect Americans in a public health emergency.
“With a more streamlined procurement process and the establishment of a National Biodefense Science Board, among other items, the BARDA bill is clearly a significant and positive step forward in strengthening our nation’s bio-security strategy,” El-Hibri said.